Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis
…, MA Christou, G Markozannes, P Altman… - … journal of chronic …, 2018 - Taylor & Francis
Rationale COPD has been perceived as being a disease of older men. However, >7 million
women are estimated to live with COPD in the USA alone. Despite a growing body of …
women are estimated to live with COPD in the USA alone. Despite a growing body of …
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD
…, R Cameron, E Bucchioni, P Altman - European …, 2014 - Eur Respiratory Soc
The Indacaterol: Switching Non-exacerbating Patients with Moderate COPD From
Salmeterol/Fluticasone to Indacaterol (INSTEAD) study investigated the effect of switching patients at …
Salmeterol/Fluticasone to Indacaterol (INSTEAD) study investigated the effect of switching patients at …
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
Background Randomized controlled trials (RCTs) indicate that long-acting bronchodilator
combinations, such as β 2 -agonist (LABA)/muscarinic antagonist (LAMA), have favorable …
combinations, such as β 2 -agonist (LABA)/muscarinic antagonist (LAMA), have favorable …
Considerations for managing chronic obstructive pulmonary disease in the elderly
GE Taffet, JF Donohue, PR Altman - Clinical Interventions in Aging, 2014 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is common in older people, with an estimated
prevalence of 10% in the US population aged ≥75 years. Inhaled medications are the …
prevalence of 10% in the US population aged ≥75 years. Inhaled medications are the …
Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety
…, A Bourdin, S Fucile, P Altman - European Respiratory …, 2020 - Eur Respiratory Soc
Short courses of systemic corticosteroids (SCS), both oral and injectable, are very effective
for the resolution of acute asthma symptoms, including exacerbations. However, the benefits …
for the resolution of acute asthma symptoms, including exacerbations. However, the benefits …
[HTML][HTML] The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation
…, DA Sandham, VJ Erpenbeck, P Altman - Respiratory …, 2018 - Springer
Asthma is characterised by chronic airway inflammation, airway obstruction and hyper-responsiveness.
The inflammatory cascade in asthma comprises a complex interplay of genetic …
The inflammatory cascade in asthma comprises a complex interplay of genetic …
Optimizing identification and management of COPD patients–reviewing the role of the community pharmacist
…, T Maguire, P Goyal, P Altman - British Journal of …, 2017 - Wiley Online Library
The aim of this paper was to propose key steps for community pharmacist integration into a
patient care pathway for chronic obstructive pulmonary disease (COPD) management. A …
patient care pathway for chronic obstructive pulmonary disease (COPD) management. A …
[HTML][HTML] Comparison of peak inspiratory flow rate via the BreezhalerŽ, ElliptaŽ and HandiHalerŽ dry powder inhalers in patients with moderate to very severe COPD …
P Altman, L Wehbe, J Dederichs, T Guerin… - BMC pulmonary …, 2018 - Springer
Background The chronic and progressive nature of chronic obstructive pulmonary disease (COPD)
requires self-administration of inhaled medication. Dry powder inhalers (DPIs) are …
requires self-administration of inhaled medication. Dry powder inhalers (DPIs) are …
[HTML][HTML] Rising costs of COPD and the potential for maintenance therapy to slow the trend
CM Blanchette, NJ Gross, P Altman - American health & drug …, 2014 - ncbi.nlm.nih.gov
Background Chronic obstructive pulmonary disease (COPD) affects an estimated 14% of
adults in the United States between the ages of 40 and 79 years. This progressive disease is …
adults in the United States between the ages of 40 and 79 years. This progressive disease is …
The impact of the prostaglandin D2 receptor 2 and its downstream effects on the pathophysiology of asthma
CE Brightling, G Brusselle, P Altman - Allergy, 2020 - Wiley Online Library
Current research suggests that the prostaglandin D 2 (PGD 2 ) receptor 2 (DP 2 ) is a
principal regulator in the pathophysiology of asthma, because it stimulates and amplifies the …
principal regulator in the pathophysiology of asthma, because it stimulates and amplifies the …